Trials / Conditions / LAL-Deficiency
LAL-Deficiency
3 registered clinical trials studyying LAL-Deficiency — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Lysosomal Acid Lipase (LAL) Deficiency Registry NCT01633489 | Alexion Pharmaceuticals, Inc. | — |
| Completed | Extension Study to Evaluate the Long-Term Safety, Tolerability, and Efficacy of SBC-102 (Sebelipase Alfa) in A NCT01488097 | Alexion Pharmaceuticals, Inc. | Phase 2 |
| Completed | Safety, Tolerability and Pharmacokinetics of SBC-102 (Sebelipase Alfa) in Adult Participants With Lysosomal Ac NCT01307098 | Alexion Pharmaceuticals, Inc. | Phase 1 / Phase 2 |